RNAi Screen Identifies MTA1 as an Epigenetic Modifier of Differentiation Commitment in Human HSPCs. Zemaitis K, Subramaniam A, Galeev R, Prosz A, et al. Exp Hematol 2022;115:20-29.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zemaitis K, Subramaniam A, Galeev R, Prosz A, et al. RNAi Screen Identifies MTA1 as an Epigenetic Modifier of Differentiation Commitment in Human HSPCs. Exp Hematol 2022;115:20-29.
PMID: 36041657